Next Article in Journal
Therapeutics in Osteoarthritis Based on an Understanding of Its Molecular Pathogenesis
Previous Article in Journal
Hippocampal MicroRNAs Respond to Administration of Antidepressant Fluoxetine in Adult Mice
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2018, 19(3), 673; https://doi.org/10.3390/ijms19030673

Xyloglucan, a Plant Polymer with Barrier Protective Properties over the Mucous Membranes: An Overview

1
Department of Microbiology and Parasitology, Pharmacy Faculty, Universitat de Barcelona (UB), Diagonal Sud, Facultat de Farmàcia, Edifici A, Av Joan XXIII, 27-31, 08028 Barcelona, Spain
2
Institut de Recerca en Nutrició i Seguretat Alimentària de la UB (INSA-UB), Universitat de Barcelona, 08921 Barcelona, Spain
3
Institute of Food Science, Technology and Nutrition (ICTAN-CSIC), 28040 Madrid, Spain
*
Author to whom correspondence should be addressed.
Received: 1 February 2018 / Revised: 23 February 2018 / Accepted: 24 February 2018 / Published: 27 February 2018
(This article belongs to the Section Bioactives and Nutraceuticals)
Full-Text   |   PDF [2617 KB, uploaded 27 February 2018]   |  

Abstract

Disruption of the epithelial barrier function has been recently associated with a variety of diseases, mainly at intestinal level, but also affecting the respiratory epithelium and other mucosal barriers. Non-pharmacological approaches such as xyloglucan, with demonstrated protective barrier properties, are proposed as new alternatives for the management of a wide range of diseases, for which mucosal disruption and, particularly, tight junction alterations, is a common characteristic. Xyloglucan, a natural polysaccharide derived from tamarind seeds, possesses a “mucin-like” molecular structure that confers mucoadhesive properties, allowing xyloglucan formulations to act as a barrier capable of reducing bacterial adherence and invasion and to preserve tight junctions and paracellular flux, as observed in different in vitro and in vivo studies. In clinical trials, xyloglucan has been seen to reduce symptoms of gastroenteritis in adults and children, nasal disorders and dry eye syndrome. Similar mucosal protectors containing reticulated proteins have also been useful for the treatment of irritable bowel syndrome and urinary tract infections. The role of xyloglucan in other disorders with mucosal disruption, such as dermatological or other infectious diseases, deserves further research. In conclusion, xyloglucan, endowed with film-forming protective barrier properties, is a safe non-pharmacological alternative for the management of different diseases, such as gastrointestinal and nasal disorders. View Full-Text
Keywords: xyloglucan; diarrhoea; gastroenteritis; nasal obstruction; rhinitis; rhinosinusitis; barrier properties; allergy; preventive measures; medical devices xyloglucan; diarrhoea; gastroenteritis; nasal obstruction; rhinitis; rhinosinusitis; barrier properties; allergy; preventive measures; medical devices
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Piqué, N.; Gómez-Guillén, M.C.; Montero, M.P. Xyloglucan, a Plant Polymer with Barrier Protective Properties over the Mucous Membranes: An Overview. Int. J. Mol. Sci. 2018, 19, 673.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top